National estimates of Hepatitis C
Published by: The Public Health Agency of Canada
Issue: Volume 46–11/12: Oral Health in Canada
Date published: November 5, 2020
Submit a manuscript
Volume 46–11/12, November 5, 2020: Oral Health in Canada
National estimates of Hepatitis C incidence, prevalence and undiagnosed proportion
Source: National estimates of Hepatitis C (HCV) incidence and prevalence in Canada, 2017. People living with Hepatitis C in Canada, 2017. Public Health Agency of Canada. Government of Canada. 2020.
Hepatitis C incidence and prevalence in Canada – Globally, viral hepatitis is one of the leading causes of death, accounting for 1.34 million deaths per year—more than HIV/AIDS, tuberculosis or malaria. HCV is not preventable by vaccine and despite the availability of effective treatment for hepatitis C, the healthcare burden in Canada associated with the complications of HCV is not decreasing. This infographic summarizes the estimates of national HCV incidence and prevalence in Canada. A more detailed report will be available in the coming months. Reporting on these measures supports the Government of Canada’s commitment to the global goal of ending viral hepatitis, HIV/AIDS and other STBBI as public health threats by 2030.
For more information:
To access the National estimates of people living with hepatitis C Infographic: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/infographic-people-living-with-hepatitis-c-2017.html
This work is licensed under a Creative Commons Attribution 4.0 International License
Report a problem or mistake on this page
- Date modified: